Hepatic sinusoidal obstruction syndrome (SOS) associated with checkpoint inhibitor therapy
Understand less common side effects of immunotherapy, now used in daily clinical practice.Consider sinusoidal obstruction syndrome (SOS) in patients who develop liver dysfunction and/or portal hypertension during or after immunotherapy for neoplastic disease.Early identification and severity assessment is crucial in facilitating prompt diagnosis and timely treatment, improving the prognosis of patients.
Authors
- Marianna Tudini
- Francesco Carubbi (ORCID: https://orcid.org/0000-0003-1958-5136)
- Claudio Ferri (ORCID: https://orcid.org/0000-0002-3594-2503)
- Luciano Mutti (ORCID: https://orcid.org/0000-0002-1578-2637)
- Marianna Litterio
- Nicole Marchetti
Institutions
- University of L'Aquila (IT)
- Italian Foundation of Myelodysplastic Syndromes (IT)
- Temple University (US)
Publication Details
- Journal
- European Journal of Case Reports in Internal Medicine
- Published
- 2024-12-13
- DOI
- https://doi.org/10.12890/2024_004885
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00